We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us

Download Mobile App


ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.

Sustainable Solar Cell Material Could Revolutionize Medical Imaging

By MedImaging International staff writers
Posted on 23 May 2023
Print article
Image: BiOI ruby-like crystals can improve medical imaging safety by lowering intensities of harmful X-rays (Photo courtesy of University of Cambridge)
Image: BiOI ruby-like crystals can improve medical imaging safety by lowering intensities of harmful X-rays (Photo courtesy of University of Cambridge)

The use of X-rays for internal body imaging has dramatically changed non-invasive medical diagnostics. Yet, the high dose of X-rays required for these imaging techniques, due to the poor performance of currently used detector materials, can harm patients, even potentially leading to cancer. Now, scientists have discovered that bismuth oxyiodide (BiOI), a material used in solar cells, can detect X-ray dose rates over 250 times lower than the best commercially used detectors. This discovery could make medical imaging safer and pave the way for new non-invasive diagnostics, such as X-ray video techniques.

BiOI is non-toxic semiconductor that absorbs visible light and remains stable in air, qualities that have led to a growing interest in its use for solar cells, photoelectrochemical cells, and energy harvesting to power smart devices over the past decade. Moreover, the presence of two heavy elements – bismuth and iodine – in BiOI facilitates strong X-ray absorption. However, prior attempts to utilize BiOI as X-ray detectors proved ineffective due to substantial energy losses caused by defects resulting from the nanocrystalline nature of the detectors.

A team of researchers, jointly led by the University of Oxford (Oxford, UK) and the University of Cambridge (Cambridge, UK), has developed and patented a scalable vapor-based method for growing high-quality single crystals of BiOI. The low defect density in these crystals facilitated stable and ultra-low dark currents, which significantly improved the sensitivity and detection limit of this material to X-rays. To understand why BiOI functions so effectively as an X-ray detector, the researchers conducted advanced optical techniques to resolve processes taking place over a trillionth of a second and combined them with simulations to link these processes with what is happening at the atomic level.

The collaborative study revealed the unique manner in which electrons couple with vibrations in the lattice. Unlike other bismuth-halide compounds, electrons in BiOI remain delocalized, allowing them to move easily and swiftly within the BiOI lattice. Simultaneously, the unique electron coupling with lattice vibrations leads to an irreversible energy loss channel that would remain even if the material was defect-free. The researchers determined that these losses could be overcome by reducing thermal energy via cooling the sample, or by applying an electric field to separate electrons from the lattice, which aligns well with how X-ray detectors function. By applying a minor electric field, electrons can be transported over a millimeter scale, facilitating the efficient extraction of electrons generated in the single crystals through X-ray absorption.

The study offers valuable insights into how delocalized charge carriers can be achieved in bismuth-halide compounds. The researchers are now focusing on leveraging these insights to develop materials with properties similar to BiOI, and on adjusting the composition of BiOI to further enhance its transport properties. They are also working on increasing the size of BiOI detectors while maintaining the exceptional properties of single crystals in order to deliver the unique benefits of BiOI to society.

“We have developed BiOI single crystals into X-ray detectors that work over 100 times better than the current state-of-the-art for medical imaging,” said Robert Hoye, Associate Professor of Inorganic Chemistry at Oxford, who led the work. “BiOI is nontoxic, stable in air, and can be grown cost-effectively and at scale. We are very excited by the potential BiOI has to make the next generation of non-invasive diagnostics more accessible, safer, and more effective.”

“Showing that these simply-processed, low-temperature grown, stable crystals can give such high sensitivity for X-ray detection is quite remarkable,” added Judith Driscoll, Professor at the University of Cambridge and co-lead on the work. “We began working on this material, BiOI, several years ago, and we find it outshines other rival materials in a range of optoelectronic/sensing applications, when toxicity and performance are considered together.”

Related Links:
University of Oxford
University of Cambridge

Gold Supplier
Portable X-Ray System
FDR Xair
Mobile DR System
Silver Supplier
Field Calibration Instrument
DAPcheck Plus
DICOM Cloud Solution
ORCA Archive

Print article
Sun Nuclear -    Mirion
FIME - Informa



view channel
Image: The AI-powered platform offers a game-changing solution for age-related disease detection and management (Photo courtesy of Freepik)

AI-Driven Imaging Platform Analyzes MRI Data for Early Detection of Age-Related Diseases

The increasing prevalence of age-related illnesses and their effects on patients, healthcare systems, and economies present a substantial challenge in the healthcare sector. As the global population ages,... Read more


view channel
Image: A novel, skull-implantable ultrasound device can open the blood-brain barrier to deliver chemotherapy (Photo courtesy of Northwestern Medicine)

Skull-Implantable Ultrasound Device Enables Powerful Chemotherapy Drug to Reach Brain Tumors

A significant challenge in treating lethal brain cancer known as glioblastoma has been the inability of powerful chemotherapy to penetrate the blood-brain barrier to target the aggressive brain tumor.... Read more

Nuclear Medicine

view channel
Image: The components of the dosimeter can fit into an 18mm by 7mm capsule (Photo courtesy of University of NUS)

Novel Ingestible Capsule X-Ray Dosimeter Enables Real-Time Radiotherapy Monitoring

Gastric cancer ranks among the most prevalent cancers worldwide. Precision is vital in modern radiotherapy, as it aims to target tumor cells while minimizing damage to healthy tissue. However, challenges... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more

Industry News

view channel
Image: The global AI-enabled medical imaging solutions market is expected to reach USD 18.36 billion in 2032 (Photo courtesy of Freepik)

Global AI-Enabled Medical Imaging Solutions Market Driven by Need for Early Disease Detection

The AI-enabled medical imaging solutions market is currently in its developmental stages, following the significant role of AI-based tools in combating the COVID-19 pandemic. The pandemic saw an upswing... Read more
Copyright © 2000-2023 Globetech Media. All rights reserved.